LeonaBio (LONA) Change in Acquisitions & Divestments (2019 - 2026)
LeonaBio's (LONA) quarterly Change in Acquisitions & Divestments came in at $5.1 million in Q1 2026, up 78.07% year-on-year from $2.8 million in Q1 2025, and up 49.26% on a QoQ basis from $3.4 million in Q4 2025.
LeonaBio (LONA) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $5.1 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 78.07% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $24.0 million, a 54.67% decrease from a year earlier, with the FY2025 full-year figure at $21.7 million, down 68.48% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $5.1 million, up from $3.4 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for LONA reached as high as $47.7 million in Q2 2023 and fell as low as $2.8 million in Q1 2025.
- Historically, Change in Acquisitions & Divestments has averaged $23.3 million across 5 years, with a median of $21.2 million in 2023.
- Across the five-year window, Change in Acquisitions & Divestments slumped 84.97% in 2025 and jumped 78.07% in 2026, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $34.8 million in 2022, then sank by 81.65% to $6.4 million in 2023, then jumped by 182.26% to $18.0 million in 2024, then tumbled by 81.15% to $3.4 million in 2025, then soared by 49.26% to $5.1 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $5.1 million in Q1 2026, $3.4 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Sep 30, 2023 | 23.50 Mn |